OPGIX
Price
$49.77
Change
-$0.39 (-0.78%)
Updated
Aug 25 closing price
Net Assets
2.4B
RSLEX
Price
$73.93
Change
-$0.52 (-0.70%)
Updated
Aug 25 closing price
Net Assets
81.34B
Interact to see
Advertisement

OPGIX vs RSLEX

Header iconOPGIX vs RSLEX Comparison
Open Charts OPGIX vs RSLEXBanner chart's image
Invesco Global Opportunities A
Price$49.77
Change-$0.39 (-0.78%)
VolumeN/A
Net Assets2.4B
American Funds SMALLCAP World R4
Price$73.93
Change-$0.52 (-0.70%)
VolumeN/A
Net Assets81.34B
OPGIX vs RSLEX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
OPGIX vs. RSLEX commentary
Aug 26, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is OPGIX is a Buy and RSLEX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RSLEX has more cash in the bank: 81.3B vs. OPGIX (2.4B). RSLEX pays higher dividends than OPGIX: RSLEX (0.62) vs OPGIX (0.01). OPGIX was incepted earlier than RSLEX: OPGIX (35 years) vs RSLEX (23 years). OPGIX (1.14) is less costly to investors than RSLEX (1.00). OPGIX is a more actively managed with annual turnover of: 62.00 vs. RSLEX (32.00). RSLEX has a lower initial minimum investment than OPGIX: RSLEX (250) vs OPGIX (1000). RSLEX annual gain was more profitable for investors over the last year : 7.73 vs. OPGIX (0.17). RSLEX return over 5 years is better than : 13.83 vs. OPGIX (-27.69).
OPGIXRSLEXOPGIX / RSLEX
Total Expense Ratio1.141.00114%
Annual Report Gross Expense Ratio1.141.00114%
Fund Existence35 years23 years-
Gain YTD6.70110.73062%
Front Load6%N/A-
Min. Initial Investment1000250400%
Min. Initial Investment IRAN/AN/A-
Net Assets2.4B81.3B3%
Annual Yield % from dividends0.010.621%
Returns for 1 year0.177.732%
Returns for 3 years6.9630.2823%
Returns for 5 years-27.6913.83-200%
Returns for 10 years24.9958.9042%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
VRCA5.990.52
+9.61%
Verrica Pharmaceuticals Inc
HALO72.210.39
+0.54%
Halozyme Therapeutics
ABLLL24.99-0.09
-0.36%
Abacus Global Management Inc. 9.875% Fixed Rate Senior Notes due 2028
OBT26.08-0.37
-1.40%
Orange County Bancorp Inc
COGT11.79-0.33
-2.72%
Cogent Biosciences